Development of a probabilistic model for Covid-19 dynamics with consideration of non-severe and severe infections

被引:2
|
作者
Mazhar, Shomaila [1 ]
Ullah, Zahid [2 ]
Shah, Syed Inayat Ali [1 ]
Badshah, Noor [3 ]
机构
[1] Islamia Coll Peshawar, Dept Math, Peshawar, Pakistan
[2] Iqra Natl Univ, Dept Civil Engn, Peshawar, Pakistan
[3] Univ Engn & Technol Peshawar, Dept Basic Sci, Peshawar, Pakistan
关键词
Covid-19; dynamics; Non-severe and severe infections; Lyapunov function; Sensitivity analysis; Parameter optimization; Prediction; LYAPUNOV FUNCTIONS; PANDEMIC MODEL; SIR; SARS-COV-2; PREDICT;
D O I
10.1016/j.aej.2023.09.067
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Covid-19 has triggered a massive global challenge with 1,576,069 overall confirmed cases, 1,545,429 recovered cases, and 30,640 deaths across Pakistan. Epidemiological models have always played an important role in understanding the dynamics of such infectious diseases. The severity of Covid-19 infection depends on several factors such as immune system and virus variants. Although detailed epidemiological models which consider these factors are generally more accurate, their complexity limits their application due to the unavailability of comprehensive historical data. Therefore, in this paper, we proposed a Susceptible-Non-severely Infected-Severely Infected-Recovered-Deceased model, for the prediction of Covid-19 infections. The proposed model broadly classifies Covid-19 infections into non-severe and severe infections. This classification is based on the overall effect of virus variants and individual immune systems. The important epidemiological proprieties of the model such as equilibrium points, stabilities and bifurcation analysis are discussed. The model is fitted to the Covid-19 data of Pakistan to predict the non-severe and severe infections over the next four months. The comparison of predicted and actual infections shows the forecasting efficiency of the model. Moreover, the prediction of a severely-infected population in the upcoming months can be of significant help to policy-makers in the efficient management of hospitalization services.
引用
收藏
页码:126 / 138
页数:13
相关论文
共 50 条
  • [1] Corticosteroids for non-severe COVID-19 infections? Too early to conclude
    Park, Sunghoon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (02): : 144 - 146
  • [2] Topological data analysis of antibody dynamics of severe and non-severe patients with COVID-19
    Blanco-Rodriguez, Rodolfo
    Ordonez-Jimenez, Fernanda
    Almocera, Alexis Erich S.
    Chinney-Herrera, Gustavo
    Hernandez-Vargas, Esteban
    MATHEMATICAL BIOSCIENCES, 2023, 361
  • [3] Antibody therapies for treatment of non-severe COVID-19
    Gourlay, Katie
    Taylor, Nicholas
    Lang, Eddy
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (03) : 883 - 885
  • [4] Antibody therapies for treatment of non-severe COVID-19
    Katie Gourlay
    Nicholas Taylor
    Eddy Lang
    Internal and Emergency Medicine, 2022, 17 : 883 - 885
  • [5] Corticosteroids for Non-severe COVID-19: Primum Non Nocere
    Muthu, Valliappan
    Sehgal, Inderpaul S.
    Dhooria, Sahajal
    Prasad, Kuruswamy Thurai
    Aggarwal, Ashutosh N.
    Agarwal, Ritesh
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (03) : 402 - 403
  • [6] Biochemical Risk Factors of Atherosclerosis in Patients with Severe and Non-severe COVID-19
    Shahali, Maryam
    Alamdary, Ashkan
    Gholami, Alireaza
    Moukhah, Rasul
    Mousavi-Nasab, Seyed Dawood
    Tehrani, Mohammad Javad Hossein
    Mardani, Rajab
    Ahmadi, Nayebali
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2024, 19 (04):
  • [7] COVID-associated arthritis after severe and non-severe COVID-19: A systematic review
    Zarpoosh, Mahsa
    Amirian, Parsa
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (10)
  • [8] A case of non-severe COVID-19 complicated by pulmonary embolism
    Akiyama, Yuto
    Horiuchi, Kohei
    Kondo, Yasushi
    Kabata, Hiroki
    Ishii, Makoto
    Fukunaga, Koichi
    RESPIROLOGY CASE REPORTS, 2020, 8 (07):
  • [9] Serum metabolomic abnormalities in survivors of non-severe COVID-19
    Li, Fang
    Fu, Lei
    Liu, Xiaoxiong
    Liu, Xin-an
    Liang, Yong
    Lv, Yueguang
    Yang, Zhiyi
    Guo, Ang
    Chen, Zhiyu
    Li, Wenbo
    Pan, Fan
    Luo, Qian
    HELIYON, 2022, 8 (09)
  • [10] Fundus evaluation in COVID-19 positives with non-severe disease
    Bypareddy, Ravi
    Rathod, B. L. Sujatha
    Shilpa, Y. D.
    Hithashree, H. R.
    Nagaraj, Kalpana Badami
    Hemalatha, B. C.
    Basumatary, Jessica
    Bekal, Deeksha
    Niranjan, R.
    Anusha, P. G.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (05) : 1271 - 1274